§ Federal grant opportunity · RFA-FD-26-012
Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional
Stephanie Bogan Grantor is accepting applications for Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional. The deadline is August 20, 2026 and the published award range is $1.1M.
Key facts
- Funder
- Stephanie Bogan Grantor
- Application deadline
- August 20, 2026
- Award range
- $1.1M
- Eligibility
- Eligibility criteria are published in the funding opportunity announcement.
- Geography
- United States
- Focus areas
- Agriculture, Consumer Protection, Food Security
- Opportunity number
- RFA-FD-26-012
Program overview
The purpose of this Notice of Funding Opportunity (NOFO) is to address topics related to the use of digital health technologies (DHTs) for remote data acquisition in clinical investigations to support drug development.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from Stephanie Bogan Grantor.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before August 20, 2026, allowing time for registration and validation.
Related grant opportunities
- StartUP Lab: U.S.-Albania Economic Leadership & Innovation Exchange
- Pax Silica Artificial Intelligence Assistance Project
- Fiscal Year 2026 National Incident Management System (NIMS)
- BJA FY 2025/2026 Project Safe Neighborhoods Formula Grant Program
- U.S-Nigeria Creative, Digital, & Innovation Economy Initiative
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.